CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 0	$ 50,000
Operating expenses:
General and administrative	693,000	718,000
Research and development	10,000	11,000
Total operating expenses	703,000	729,000
Loss from operations	(703,000)	(679,000)
Other income (expense):
Gain (Loss) on fair value adjustment of investments	(477,000)	(2,030,000)
Gain on forgivenes of debt	15,000	0
Interest expense	0	(21,000)
Total other income (expense)	(462,000)	(2,051,000)
NET LOSS	$ (1,165,000)	$ (2,730,000)
LOSS PER COMMON SHARE:
Weighted average number of common shares outstanding (Basic and Diluted)	559,281,064	559,281,064
Basic and Diluted loss per common share (Basic and Diluted)	$ (0.00)	$ (0.00)